Shionogi (4507.T) Financial Analysis & Valuation | Quarter Chart
Shionogi (4507.T)
4507.TPrice: $18.84
Fair Value: 🔒
🔒score
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Xofluza, an influenza virus drug; and Tivicay ... more
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of phar... more
Description
Shares
| Market Cap | $16.03B | Exchange | JPX |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | JP | CEO | Isao Teshirogi |
| IPO Date | 2000-01-04 | CAGR | 0.01% |
| Employees | 4,955 | Website | www.shionogi.com |
| Div. Yield | 2.35% | Payout Ratio | 0.27% |
| Buy Back Yield | — | Total Yield | 2.35% |
4507.T chart loading...
Fundamentals
Technicals
| Enterprise Value | $2925.06B | P/E Ratio | 12.45 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 5.14 | P/B Ratio | 1.53 |
| P/CF Ratio | 12.03 | P/FCF Ratio | 12.91 |
| EPS | $1.51 | EPS Growth 1Y | 20.35% |
| EPS Growth 3Y | 16.26% | EPS Growth 5Y | 94.16% |
| Revenue Growth 1Y | 14.01% | Gross Margin | 0.82% |
| Operating Margin | 0.32% | Profit Margin | 0.41% |
| ROE | 0.14% | ROA | 0.08% |
| ROCE | 0.09% | Current Ratio | 1.58 |
| Quick Ratio | 1.46 | Cash Ratio | 0.86 |
| Debt/Equity | 0.41 | Interest Coverage | 18.62 |
| Altman Z Score | 3.24 | Piotroski Score | 4 |